-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, T3vgnNFC2QpaFRtkb4pCboMTx4o2hyMx1dK/c1Hk3evhhh0GmfPcQfqtW/R9sPyj M18kEAhfrMWSViUbSOvpGQ== /in/edgar/work/20000721/0001116679-00-000009/0001116679-00-000009.txt : 20000920 0001116679-00-000009.hdr.sgml : 20000920 ACCESSION NUMBER: 0001116679-00-000009 CONFORMED SUBMISSION TYPE: SC 13D/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20000721 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: INTERLEUKIN GENETICS INC CENTRAL INDEX KEY: 0001037649 STANDARD INDUSTRIAL CLASSIFICATION: [8071 ] IRS NUMBER: 943123681 STATE OF INCORPORATION: TX FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A SEC ACT: SEC FILE NUMBER: 005-53249 FILM NUMBER: 676525 BUSINESS ADDRESS: STREET 1: 100 NE LOOP 410 STREET 2: STE 820 CITY: SAN ANTONIO STATE: TX ZIP: 78216-4749 BUSINESS PHONE: 2103496400 MAIL ADDRESS: STREET 1: 100 NE LOOP 410 STREET 2: STE 820 CITY: SAN ANTONIO STATE: TX ZIP: 78216 FORMER COMPANY: FORMER CONFORMED NAME: MEDICAL SCIENCE SYSTEMS INC DATE OF NAME CHANGE: 19971003 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: MSSI LLC CENTRAL INDEX KEY: 0001094746 STANDARD INDUSTRIAL CLASSIFICATION: [0000 ] IRS NUMBER: 134075839 STATE OF INCORPORATION: NY FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D/A BUSINESS ADDRESS: STREET 1: C/O BATTLE FOWLER STREET 2: 75 EAST 55TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 BUSINESS PHONE: 2128567000 MAIL ADDRESS: STREET 1: C/O BATTLE FOWLER LLP STREET 2: 75 EST 55TH STREET CITY: NEW YORK STATE: NY ZIP: 10022 SC 13D/A 1 0001.txt AMENDMENT NO. 3 TO SCHEDULE 13D UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 3 (Final))* INTERLEUKIN GENETICS, INC. -------------------------- (Name of Issuer) Common Stock, no par value -------------------------- (Title of Class of Securities) 458738 10 1 ----------- (CUSIP Number) MSSI LLC c/o Richard L. Fisher 299 Park Avenue New York, NY 10017 (212) 752-5000 copy to: John N. Turitzin Paul, Hastings, Janofsky & Walker LLP 75 East 55th Street New York, NY 10022 (212) 318-6000 -------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) July 14, 2000 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of this Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), (f) or (g), check the following box / /. Note: Six copies of this statement, including all exhibits, should be filed with the Commission. See Rule 13d-1(a) for other parties to whom copies are to be sent. * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). Page 1 of 6 Pages NYC55/6324.1 CUSIP No. 458738 10 1 SCHEDULE 13D - -------------------------------------------------------------------------------- 1 NAME OF REPORTING PERSON S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON MSSI LLC 13-4075839 - -------------------------------------------------------------------------------- 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) / / (b) /X/ - -------------------------------------------------------------------------------- 3 SEC USE ONLY - -------------------------------------------------------------------------------- 4 SOURCE OF FUNDS OO - -------------------------------------------------------------------------------- 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e) / / - -------------------------------------------------------------------------------- 6 CITIZENSHIP OR PLACE OF ORGANIZATION New York - -------------------------------------------------------------------------------- 7 SOLE VOTING POWER - 0 - NUMBER OF ----------------------------------------------------------------- SHARES 8 SHARED VOTING POWER BENEFICIALLY - 0 - OWNED BY ----------------------------------------------------------------- EACH 9 SOLE DISPOSITIVE POWER REPORTING PERSON WITH - 0 - ----------------------------------------------------------------- 10 SHARED DISPOSITIVE POWER - 0 - - -------------------------------------------------------------------------------- 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON - 0 - - -------------------------------------------------------------------------------- 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES / / - -------------------------------------------------------------------------------- 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) - 0 - - -------------------------------------------------------------------------------- 14 TYPE OF REPORTING PERSON OO - -------------------------------------------------------------------------------- Page 2 of 6 Pages NYC55/6324.1 Amendment No. 3 (Final) to Schedule 13D This Amendment No. 3 to Schedule 13D amends and supplements the original Schedule 13D, dated September 13, 1999, as amended by Amendment No.1 thereto, dated November 12, 1999, and as amended by Amendment No. 2 thereto, dated March 14, 2000, filed on behalf of MSSI LLC (the "Company"), with respect to the ownership of Common Stock, no par value ("Common Stock"), of Interleukin Genetics, Inc., a Texas corporation (the "Issuer"). I. Item 5 of the Schedule 13D "Interest in Securities of the Issuer" is amended and restated as follows: (a) and (b). As of the close of business on July 14, 2000, the Company did not beneficially own or otherwise have the sole or shared power to vote or dispose of any shares of Common Stock. (c). From March 21, 2000 through April 6, 2000, the Company sold 164,800 shares of Common Stock in open market transactions as set forth on Schedule I attached hereto. On July 14, 2000, the Company distributed its remaining 1,335,200 shares of Common Stock to its members in proportion to each member's percentage interest in the Company as set forth on Schedule II attached hereto. No consideration was received by the Company in exchange for the shares of Common Stock. (d). Not applicable. (e). As of the close of business on July 14, 2000, the Company ceased to be the beneficial owner of more than five percent of the Issuer's outstanding shares of Common Stock. Accordingly, the Company intends not to further amend its report on Schedule 13D to reflect changes in the facts set forth therein which may occur after the date hereof. Page 3 of 6 Pages NYC55/6324.1 SCHEDULE I Date Amount of Securities Sold Net Proceeds per Share - -------------------------------------------------------------------------------- March 21, 2000 10,000 $10.25 - -------------------------------------------------------------------------------- March 22, 2000 10,000 11.31 - -------------------------------------------------------------------------------- March 23, 2000 20,000 12.64 - -------------------------------------------------------------------------------- March 24, 2000 10,000 12.61 - -------------------------------------------------------------------------------- March 27, 2000 12,500 12.70 - -------------------------------------------------------------------------------- March 28, 2000 14,000 11.64 - -------------------------------------------------------------------------------- March 29, 2000 10,000 10.42 - -------------------------------------------------------------------------------- March 30, 2000 10,000 9.57 - -------------------------------------------------------------------------------- March 31, 2000 20,000 9.22 - -------------------------------------------------------------------------------- April 3, 2000 10,000 10.01 - -------------------------------------------------------------------------------- April 4, 2000 8,900 8.37 - -------------------------------------------------------------------------------- April 5, 2000 9,400 8.09 - -------------------------------------------------------------------------------- April 6, 2000 20,000 8.13 - -------------------------------------------------------------------------------- Total 164,800 - -------------------------------------------------------------------------------- Page 4 of 6 Pages NYC55/6324.1 SCHEDULE II Member Percentage Interest Shares of Common Stock - ------ ------------------- ---------------------- - -------------------------------------------------------------------------------- Arnold Fisher 19% 253,688 - -------------------------------------------------------------------------------- Richard L. Fisher 19% 253,688 - -------------------------------------------------------------------------------- M. Anthony Fisher 19% 253,688 - -------------------------------------------------------------------------------- Kenneth Fisher 19% 253,688 - -------------------------------------------------------------------------------- Steven Fisher 19% 253,688 - -------------------------------------------------------------------------------- Martin L. Edelman 5% 66,760 - -------------------------------------------------------------------------------- Page 5 of 6 Pages NYC55/6324.1 SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. MSSI LLC By: /s/ M. Anthony Fisher --------------------- Name: M. Anthony Fisher Title: Managing Member Dated: July 20, 2000 Page 6 of 6 Pages NYC55/6324.1 -----END PRIVACY-ENHANCED MESSAGE-----